Management of recurrent viral Hepatitis B and C after liver transplantation

ArticleinCurrent Gastroenterology Reports 8(1):60-6 · March 2006with1 Read
DOI: 10.1007/s11894-006-0065-x · Source: PubMed

    Abstract

    Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contraindication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment outcomes for HCV and HBV in the period following liver transplant.